Online communities and social networks like Twitter and Facebook have become important real-world data repositories that can be leveraged by life sciences organizations to gain insight into the patient experience, as well as to identify potential safety issues related to drugs and devices – otherwise known as safety signal detection.
Perficient’s director of safety and pharmacovigilance, Dr. Rodney Lemery, discussed the methods, benefits, and challenges involved with mining real-world data for adverse event drug reactions and other safety signals.
Pharma Marketing Digital Trends to Watch in 2020. A closer look at some of the future directions that Pharma Marketing need in 2020 to arm themselves for in full readiness for the next 12 Months
mHealth Israel_Ralf Jahns_Research2Guidance_The EU Countries’ mHealth App Mar...Levi Shapiro
The EU Countries’ mHealth App Market Ranking 2015, by Ralf Gordon Jahns, CEO of Research2Guidance. Presentation made at the mHealth Israel Investors Summit, June, 2015
US FOOD AND DRUG ADMINISTRATION’S SOCIAL MEDIA USAGE GUIDELINES: ARE PHARMACE...Clarinda Cerejo
This poster was presented by representatives from the Cactus Life Sciences team at the 15th Annual Meeting of the International Society for Medical Publication Professionals (ISMPP), 2019.
Pharma Marketing Digital Trends to Watch in 2020. A closer look at some of the future directions that Pharma Marketing need in 2020 to arm themselves for in full readiness for the next 12 Months
mHealth Israel_Ralf Jahns_Research2Guidance_The EU Countries’ mHealth App Mar...Levi Shapiro
The EU Countries’ mHealth App Market Ranking 2015, by Ralf Gordon Jahns, CEO of Research2Guidance. Presentation made at the mHealth Israel Investors Summit, June, 2015
US FOOD AND DRUG ADMINISTRATION’S SOCIAL MEDIA USAGE GUIDELINES: ARE PHARMACE...Clarinda Cerejo
This poster was presented by representatives from the Cactus Life Sciences team at the 15th Annual Meeting of the International Society for Medical Publication Professionals (ISMPP), 2019.
The explosion in the number of applications (apps) designed for the medical and wellness sectors has been noted by many. Recently we have seen increased presence of truly medical apps, in addition to consumer health and wellbeing apps, designed for clinical professionals and patients with medical conditions.
Consumer based mHealth apps typically allow people to do old things in new ways, such as recording health measures digitally rather than on paper. We see this also with medical apps, where increases in the quality and efficiency of existing health care models provide clinical staff with digital tools that replace paper based documentation. In rare and exciting cases we are also seeing mHealth applications that are doing things in entirely new ways to drive real innovation in health care delivery through mobile devices.
The aim of the tutorial is to highlight real world, high impact mobile research that is relevant to the key discipline of Mobile HCI. Thus, the tutorial will be application rather than academically focused. The tutorial will highlight the wide range of mHealth applications available that go far beyond trackers and behavior change tools and encourage researchers to look beyond consumer applications in their research. Four key areas of mHealth applications will be covered including Apps for the HealthyWell, mHealth in Hospitals, Practice and Clinical Apps and Patient Apps and will cover applications for health assessment, treatment and triage, behavior change, chronic illness, mental health, adolescent health, rehabilitation and age care with a focus on the need for rigorous evaluation and efficacy analysis.
It is all about the Digital and Social Media in Pharma industry with special reference to India. In this described physicians preference with the key digital indicator of India. In this also given the list of top 10 companies in Indian pharma sector. At the end, Case-study of Pfizer is also described...
The Impact and Use of Social Media in PharmacovigilanceCovance
This white paper examines how the influence and reach of the internet and social media can be harnessed to drive valuable outcomes for the PV industry. In this paper, we look at available regulatory guidelines, current state and future considerations for use of social media in PV, possible areas of influence, expected challenges, potential solutions and next steps.
Choosing The Right CMS In An Evolving Marketing EcosystemGeonetric
Integrated marketing systems are all in vogue and yesterday's content management systems have become today's "experience platforms." While the art of getting content onto a web page is still important, there's a growing awareness that just being there is not the goal. Healthcare organizations of all sizes are taking a critical look at how their tools and techniques align, integrate and provide the insights necessary to help their digital marketing teams drive engagement, attract patients and promote their brands.
Health Datapalooza 2013: Blue Button Plus For Data Holders - Ryan PanchadsaramHealth Data Consortium
Health Datapalooza IV: June 3rd-4th, 2013
Unlocking Clinical & Claims Data by Giving Consumers Access: Blue Button Plus For Data Holders
Moderator:
Ryan Panchadsaram, Senior Advisor, White House Office of Science and Technology Policy
Speakers:
Kym Martin, Three-time cancer survivor
Jon R. Cohen, Chief Medical Officer, Quest Diagnostics
Craig Lipset, Head of Clinical Innovation, Pfizer
Mark Savage, Director of Health IT Policy and Programs, National Partnership for Women & Families
Consumers can be engaged, active participants in their own health and partners in reducing health care costs. But first, they need access to their own personal health information, and they need tools and services that use this information to help them make better choices. The panel will bring together payers, providers, and other data holders who will discuss the value proposition for sharing data with consumers. They will demonstrate Blue Button Plus, which makes it easy for data holders to share personal health information with consumers and their applications in a standardized, automated format.
Digital marketing for pharmaceutical companiesdigitalsaline
“I think the biggest innovations of the 21st Century will be at the intersection of Biology and technology. A new era is beginning” –Steve Jobs
Like all other businesses, the healthcare and pharmaceutical industry is also looking keenly at digital for enhancing and marketing their products. Social media and mobile apps are set to play a bigger role in the growth of this business. This will help people to catch up with tech-savvy emerging markets peers, approximately half the pharmaceutical companies are expected to allocate more than a fifth of their marketing budget to digital marketing by 2019.
Website and applications for medical knowledge sharing such as Knowledge Genie to those having on virtual and augmented reality to engage with doctors and patients, Pharmaceutical industries are getting their marketing strategy aligned to digital prospects.
March 19, 2011 presentation at the Annual conference for the Association for Prevention Teaching and Research on opportunities for students to be engaged with mHealth.
More mobile phones are sold globally over 24 hours than babies born - the proliferation of mobile phones is now outpacing the human population. It should come as no surprise that the obtaining and sharing of health information thru mobile is projected to grow exponentially. Mobile in fact is the only media time that is currently growing.
No matter the regional or local audience---The creation of mobile strategies and campaigns are inherently vast, encompassing; m.sites, apps, social, banners, SMS/MMS, gaming, QR codes, video, augmented reality and much more.
Given the infinite canvas of mobile marketing, in this presentation we’ll explore the importance of an engaging mobile experience that ultimately adds value and improves the users life.
Mobile is truly an indispensable part of all our lives in this hyper-connected world where 91% of adults have their mobile within arm's reach 24/7. And like never before this is the era of the Mighty Mobile in health, wellness and fitness!
IRIDA: A Federated Bioinformatics Platform Enabling Richer Genomic Epidemiolo...William Hsiao
Introducing BCCDC and Public Health Microbiology (PHM)
Current State of PHM
Sequence Technology Advancement -> revolution of PHM
Genomic Epidemiology
Amount of Sequence Data Produced
Need to Process the data – Introduction to IRIDA
Need of Metadata and Ontology
Software to improve data sharing
How research microbiology and PHM can joint effort
IMMEM XI: Ten Simple Rules to Build a Better Public Health Genomic Epidemiolo...William Hsiao
In this presentation, I provided 10 simple rules to build a better public health genomic epidemiology analysis platform. I encourage people to adopt some of these rules to make their applications more accessible and more useful to the public health agencies.
Pharma must change the ways it deals with physicians and patients. These three digital health technology companies will revolutionize the way Pharma does business.
Life science companies need to ensure their business initiatives take advantage of social media analytics. Read about the challenge of maximizing the opportunity and generating value from real world patient insights.
The explosion in the number of applications (apps) designed for the medical and wellness sectors has been noted by many. Recently we have seen increased presence of truly medical apps, in addition to consumer health and wellbeing apps, designed for clinical professionals and patients with medical conditions.
Consumer based mHealth apps typically allow people to do old things in new ways, such as recording health measures digitally rather than on paper. We see this also with medical apps, where increases in the quality and efficiency of existing health care models provide clinical staff with digital tools that replace paper based documentation. In rare and exciting cases we are also seeing mHealth applications that are doing things in entirely new ways to drive real innovation in health care delivery through mobile devices.
The aim of the tutorial is to highlight real world, high impact mobile research that is relevant to the key discipline of Mobile HCI. Thus, the tutorial will be application rather than academically focused. The tutorial will highlight the wide range of mHealth applications available that go far beyond trackers and behavior change tools and encourage researchers to look beyond consumer applications in their research. Four key areas of mHealth applications will be covered including Apps for the HealthyWell, mHealth in Hospitals, Practice and Clinical Apps and Patient Apps and will cover applications for health assessment, treatment and triage, behavior change, chronic illness, mental health, adolescent health, rehabilitation and age care with a focus on the need for rigorous evaluation and efficacy analysis.
It is all about the Digital and Social Media in Pharma industry with special reference to India. In this described physicians preference with the key digital indicator of India. In this also given the list of top 10 companies in Indian pharma sector. At the end, Case-study of Pfizer is also described...
The Impact and Use of Social Media in PharmacovigilanceCovance
This white paper examines how the influence and reach of the internet and social media can be harnessed to drive valuable outcomes for the PV industry. In this paper, we look at available regulatory guidelines, current state and future considerations for use of social media in PV, possible areas of influence, expected challenges, potential solutions and next steps.
Choosing The Right CMS In An Evolving Marketing EcosystemGeonetric
Integrated marketing systems are all in vogue and yesterday's content management systems have become today's "experience platforms." While the art of getting content onto a web page is still important, there's a growing awareness that just being there is not the goal. Healthcare organizations of all sizes are taking a critical look at how their tools and techniques align, integrate and provide the insights necessary to help their digital marketing teams drive engagement, attract patients and promote their brands.
Health Datapalooza 2013: Blue Button Plus For Data Holders - Ryan PanchadsaramHealth Data Consortium
Health Datapalooza IV: June 3rd-4th, 2013
Unlocking Clinical & Claims Data by Giving Consumers Access: Blue Button Plus For Data Holders
Moderator:
Ryan Panchadsaram, Senior Advisor, White House Office of Science and Technology Policy
Speakers:
Kym Martin, Three-time cancer survivor
Jon R. Cohen, Chief Medical Officer, Quest Diagnostics
Craig Lipset, Head of Clinical Innovation, Pfizer
Mark Savage, Director of Health IT Policy and Programs, National Partnership for Women & Families
Consumers can be engaged, active participants in their own health and partners in reducing health care costs. But first, they need access to their own personal health information, and they need tools and services that use this information to help them make better choices. The panel will bring together payers, providers, and other data holders who will discuss the value proposition for sharing data with consumers. They will demonstrate Blue Button Plus, which makes it easy for data holders to share personal health information with consumers and their applications in a standardized, automated format.
Digital marketing for pharmaceutical companiesdigitalsaline
“I think the biggest innovations of the 21st Century will be at the intersection of Biology and technology. A new era is beginning” –Steve Jobs
Like all other businesses, the healthcare and pharmaceutical industry is also looking keenly at digital for enhancing and marketing their products. Social media and mobile apps are set to play a bigger role in the growth of this business. This will help people to catch up with tech-savvy emerging markets peers, approximately half the pharmaceutical companies are expected to allocate more than a fifth of their marketing budget to digital marketing by 2019.
Website and applications for medical knowledge sharing such as Knowledge Genie to those having on virtual and augmented reality to engage with doctors and patients, Pharmaceutical industries are getting their marketing strategy aligned to digital prospects.
March 19, 2011 presentation at the Annual conference for the Association for Prevention Teaching and Research on opportunities for students to be engaged with mHealth.
More mobile phones are sold globally over 24 hours than babies born - the proliferation of mobile phones is now outpacing the human population. It should come as no surprise that the obtaining and sharing of health information thru mobile is projected to grow exponentially. Mobile in fact is the only media time that is currently growing.
No matter the regional or local audience---The creation of mobile strategies and campaigns are inherently vast, encompassing; m.sites, apps, social, banners, SMS/MMS, gaming, QR codes, video, augmented reality and much more.
Given the infinite canvas of mobile marketing, in this presentation we’ll explore the importance of an engaging mobile experience that ultimately adds value and improves the users life.
Mobile is truly an indispensable part of all our lives in this hyper-connected world where 91% of adults have their mobile within arm's reach 24/7. And like never before this is the era of the Mighty Mobile in health, wellness and fitness!
IRIDA: A Federated Bioinformatics Platform Enabling Richer Genomic Epidemiolo...William Hsiao
Introducing BCCDC and Public Health Microbiology (PHM)
Current State of PHM
Sequence Technology Advancement -> revolution of PHM
Genomic Epidemiology
Amount of Sequence Data Produced
Need to Process the data – Introduction to IRIDA
Need of Metadata and Ontology
Software to improve data sharing
How research microbiology and PHM can joint effort
IMMEM XI: Ten Simple Rules to Build a Better Public Health Genomic Epidemiolo...William Hsiao
In this presentation, I provided 10 simple rules to build a better public health genomic epidemiology analysis platform. I encourage people to adopt some of these rules to make their applications more accessible and more useful to the public health agencies.
Pharma must change the ways it deals with physicians and patients. These three digital health technology companies will revolutionize the way Pharma does business.
Life science companies need to ensure their business initiatives take advantage of social media analytics. Read about the challenge of maximizing the opportunity and generating value from real world patient insights.
Unleashing the Potential of Social Media in Drug Safety Exploring the Increas...Covance
Pharmacovigilance has grown more complex over the past decade with higher data volumes, changing regulations, rise of social media, and innovative digital advances. **Disclaimer: This article was previously published. Sciformix is now a Covance company.
An Industry Collaboration's Perspectives on the Value of Patient Support Prog...TransCelerate
The Value of Safety Information Data Sources Initiative will seek to identify sources of safety information for a single high value valid cases and develop a proposed method for aggregate reporting of lower value cases.
Big data e social media nel Pharma - IMS Health Italia @Aboutpharma Digital S...IMS Health Italia
Social media e Pharma sono inconciliabili?
Ne abbiamo parlato come keynote speaker al Digital Summit di Aboutpharma del'8 giugno 2016, dimostrando come un'azienda farmaceutica utilizzando gli strumenti giusti possa seguire tutto quanto è pubblicato online ed estrarre da questi big (real-world ) data tutto il valore.
Capgemini Consulting: Taking the Digital Pulse: Why Healthcare Providers Need...VIRGOkonsult
Capgemini Consulting: Taking the Digital Pulse: Why Healthcare Providers Need an Urgent Digital Check-Up
"Most Healthcare Providers do not Use Mobile Channels Effectively"
Taking the Digital Pulse: Why Healthcare Providers Need an Urgent Digital Che...Capgemini
Digital technologies are altering the very fabric of the traditional healthcare delivery model. Consumers are actively embracing digital tools to take charge of their health.
Consider this: no less than 86% of respondents in a survey reported that they wanted to take a more proactive role in their healthcare decisions, and 76% reported that they have the tools and information to do so. Social media and mobile platforms are becoming increasingly important channels for consumers. A survey found that 45% of respondents search for health information and close to 34% ask for health-related advice on social media. channels. The four million mobile health app downloads that occur every day also give consumers an easy way to track their health.
So how is the healthcare industry responding to these new opportunities? Are the industry and the current healthcare delivery model adapting to changing consumer needs rapidly enough? To obtain a clearer picture of current digital readiness, we conducted a survey of global healthcare players. We also compared the digital maturity of the healthcare industry with that of other industries, based on a previous study conducted jointly with the MIT Center for Digital Business. The results will probably not come as a surprise to many of us.
We found that healthcare is significantly less mature than many industries in the adoption of digital technologies. Our survey also revealed a wide disparity in the digital maturity of healthcare providers. Only 33% were found to be digitally mature or Digirati, while the majority were found to be lagging in the use of digital technologies.
The world is quite a different place than it was six months ago, and with the 2020 holiday season fast approaching, the pressure is on to meet revenue goals in what’s been an uncertain year.
In August, we surveyed 154 marketing executives to find out what they think is likely to happen this holiday season and how they are preparing for it. The results are fascinating, and we’ve distilled them into clear actions you can take right now to adapt and prepare for a very different 2020 holiday season.
In this webinar, Eric Enge (Principal, Digital Marketing at Perficient) and Jim Hertzfeld (Chief Strategist, Digital at Perficient) discussed:
How marketers have already adapted and where they see the most opportunity moving forward
What will be different this holiday season and how to adjust your strategy accordingly
Ways to identify and meet changing customer expectations, wants, and needs
How to determine if your priorities or investments should change
What actions you can take right now to be successful
Transforming Pharmacovigilance Workflows with AI & Automation Perficient, Inc.
Medical information call centers have an opportunity to transform the way they capture, code, and analyze adverse events (AEs) and product quality complaints (PQCs) with artificial intelligence (AI) and automation.
The use of such innovative technology improves data quality and consistency, compliance, and operational efficiency. It helps reduce the frequency of your pharmacovigilance (PV) operations resources going home, saying, “I have more to do at the end of the day than I did when I started."
Our one-hour, on-demand webinar shows you how you can use AI and automation to turbo-charge your end-to-end PV system. Use cases and demonstrations will include:
Analyzing safety data
Auto-coding verbatim terms to official medical dictionary terms
Auto-creating an AE case in your database
Converting speech to text
The Secret to Acquiring and Retaining Customers in Financial ServicesPerficient, Inc.
Data, when leveraged effectively, can help you segment and target customers, analyze spending habits, and can create a personalized experience that builds value and customer loyalty.
Without a 360-degree view of your customers, you can’t properly target them with real-time personalized offers, advice, and other services. In addition, lack of customer intelligence creates lost opportunities for banks and insurers to cross-sell and upsell new products and services.
Our one-hour webinar covered how customer intelligence platforms can help you engage, acquire, and retain customers.
Oracle Strategic Modeling Live: Defined. Discussed. Demonstrated.Perficient, Inc.
The only thing certain about forecasting in a volatile economy is that the future is unpredictable. Historically, organizations have effectively utilized statistical techniques for short-term business planning, but leveraging actuals no longer allows us to predict the future. The ability to be prepared, responsive, and agile under these conditions is becoming a crucial success factor. Oracle Strategic Modeling can help you better navigate change to cope with uncertainty.
If your CFO’s questions regarding earnings, liquidity, and cash flow are unceasing and far-reaching, watch our on-demand webinar for a deep dive into strategic modeling. We modeled real-world scenarios to show how you can:
Quickly and easily develop a hierarchical model of your business
Leverage multiple pre-built functions to forecast key performance drivers
Provide transparency on forecasted financials via audit trail
Utilize goal seek to set financial targets and estimate the financials drivers necessary to achieve it
Perform sophisticated “what-if” analysis via simulations to improve the accuracy of your forecast
Use built-in dashboard functionality to deliver powerful reporting capabilities
While many stay-at-home orders have been lifted, consumers’ new digital buying behaviors and habits are here to stay. Watch our panel discussion on the accelerated need for commerce and learn how commerce and content can transform our digital economy.
Topics include:
-What is the “experience economy” and how do you leverage it? -If you move beyond product and price, what’s next?
-How business models have shifted and what you can do to break down silos and leverage new processes to capture the digital dollar.
-How organizations have built agile teams to address the ever-changing needs of customers, including responsive approaches that address the omnichannel consumer.
-Technologies that are best suited to enable your business and customers – and how headless commerce has changed the game.
-How the future of commerce is changing, and what you should do now to prepare.
Our panel features Jordan Jewell, IDC Research analyst known for his insight into the commerce industry. Joining him from Perficient is general manager Brian Beckham, who brings deep expertise in content management and empowering organizations in their digital transformations. Rounding out the panel is Episerver’s Joey Moore, who has spent the last decade helping organizations across the globe advance their digital maturity.
Centene's Financial Transformation Journey: A OneStream Success StoryPerficient, Inc.
Centene, a large multi-line managed care organization, was looking to modernize and streamline its corporate performance management (CPM) applications.
Centene had to move data between platforms multiple times during the close process so that close data could be fully consolidated and made available for reporting. This process had numerous challenges and inefficiencies that Centene wished to improve upon so that they could provide a more streamlined and more transparent process to the functional teams that leverage consolidated financials in their systems for reporting and analysis.
Centene chose OneStream XF for global and US consolidations, currency conversion, eliminations, and ownership percentage.
Michael Vannoni, director, financial systems solutions discussed the migration to OneStream XF including:
-Factors leading to the selection of OneStream XF
-Details of the solution design
-Benefits realized with global consolidation implementation
-Future planned enhancements
WHODrug Koda, developed by Uppsala Monitoring Centre (UMC), is an automated coding service, which uses artificial intelligence (AI) to automate the coding of drug names and ATC selections, improving consistency and operational efficiency. It can also be used to accelerate dictionary upgrades, including the transition from WHODrug B2 format to B3.
Through API (Application Programming Interface) web services, the coding engine can be integrated with custom or off-the-shelf drug safety, medical coding, or data management systems.
In this webinar, Perficient and UMC discussed WHODrug Koda and how you can integrate it into your medical coding activities.
Preparing for Your Oracle, Medidata, and Veeva CTMS Migration ProjectPerficient, Inc.
There are multiple reasons why companies migrate to a new clinical trial management system (CTMS). Still, the two most common are mergers and acquisitions (i.e., CTMS consolidation) and the desire to switch CTMS vendors. Regardless of the reason, many of the best practices, processes, and tools are the same.
In this webinar, we looked at the migration approaches taken across several case studies. You’ll come away with an understanding of:
Pros and cons of each CTMS migration method
Types of migration tools, including APIs, ETL tools, and adapters
Approximate timelines and costs associated with each migration method
The topics discussed in this webinar can be applied to any CTMS migration project, whether you’re moving to or from Oracle’s Siebel CTMS, Medidata’s Rave CTMS, and Veeva’s Vault CTMS.
Accelerating Partner Management: How Manufacturers Can Navigate Covid-19Perficient, Inc.
The pandemic has ushered in a new normal for manufacturers, and the impact of digital communication is more important than ever.
View our on-demand webinar with Tony Kratovil, Regional Vice President of Manufacturing at Salesforce, and Eric Dukart, National Sales Executive at Perficient. They covered why the right digital strategies are critical for manufacturers in the wake of COVID-19.
Our webinar covered:
Current challenges with forecasting, collaboration, and disruptions to distribution networks.
Insights for stabilizing operations, accelerating partner management, and developing a digital strategy that differentiates your business.
Candid Q&A with real-world examples.
New Work.com resources to help manufacturers restart safely and rebuild.
Tools and resources to move forward – fast.
The Critical Role of Audience Intelligence with Eric Enge and Rand FishkinPerficient, Inc.
Things move quickly in marketing. How do you identify what your customers need and how you can help? Now more than ever, audience intelligence is the key.
Audience intelligence is about understanding your target customers, their needs, what resonates with them, and how you can reach them. Eric Enge (Digital Marketing Principal, Perficient) and Rand Fishkin (Co-Founder & CEO, SparkToro) discussed this topic live on May 7, 2020. Watch to hear tactics for gaining a better understanding of your customers, how to use audience intelligence to optimize your marketing now, and more.
Cardtronics, the global leader in ATM deployment and management, decided to retire its on-premises Hyperion solution to gain the operational efficiencies, features, and functionality provided by a best-in-class cloud solution.
Cardtronics chose Oracle EPM Cloud including Financial Consolidation and Close, Planning, Management Reporting, Account Reconciliation, Enterprise Data Management, as well as Oracle Analytics Cloud.
In this video, project owner Richard Ng, director, financial systems, Cardtronics, discusses the migration to Oracle EPM Cloud including:
Multi-release 18-month deployment schedule across multiple countries
Benefits of a global Chart of Accounts for ERP and EPM
Seamless integration across ERP Cloud, HCM Cloud, and EPM Cloud
Preparing for Project Cortex and the Future of Knowledge ManagementPerficient, Inc.
Microsoft has turned traditional enterprise content management on its head with its recent announcement of Project Cortex.
Project Cortex uses advanced artificial intelligence to harness collective knowledge from across the enterprise and automatically organize it into shared topics like projects, products, processes, and customers. Using AI, Cortex creates a knowledge network based on relationships among topics, content, and people and delivers it in the apps you use every day – Office, Outlook, and Teams.
This webinar examined Project Cortex in more detail, including:
• What is Project Cortex?
• Why is Project Cortex different than other knowledge network projects previously introduced?
• How does incorporating AI and automation change the game?
• What is possible with Project Cortex?
• What can you do to prepare?
Utilizing Microsoft 365 Security for Remote Work Perficient, Inc.
With an increasingly mobile workforce, and the spread of shadow IT, the rapid rise of cybercrime - companies must find unique ways to effectively manage their sprawling SaaS portfolio.
UiPath Test Automation using UiPath Test Suite series, part 3DianaGray10
Welcome to UiPath Test Automation using UiPath Test Suite series part 3. In this session, we will cover desktop automation along with UI automation.
Topics covered:
UI automation Introduction,
UI automation Sample
Desktop automation flow
Pradeep Chinnala, Senior Consultant Automation Developer @WonderBotz and UiPath MVP
Deepak Rai, Automation Practice Lead, Boundaryless Group and UiPath MVP
The Art of the Pitch: WordPress Relationships and SalesLaura Byrne
Clients don’t know what they don’t know. What web solutions are right for them? How does WordPress come into the picture? How do you make sure you understand scope and timeline? What do you do if sometime changes?
All these questions and more will be explored as we talk about matching clients’ needs with what your agency offers without pulling teeth or pulling your hair out. Practical tips, and strategies for successful relationship building that leads to closing the deal.
Securing your Kubernetes cluster_ a step-by-step guide to success !KatiaHIMEUR1
Today, after several years of existence, an extremely active community and an ultra-dynamic ecosystem, Kubernetes has established itself as the de facto standard in container orchestration. Thanks to a wide range of managed services, it has never been so easy to set up a ready-to-use Kubernetes cluster.
However, this ease of use means that the subject of security in Kubernetes is often left for later, or even neglected. This exposes companies to significant risks.
In this talk, I'll show you step-by-step how to secure your Kubernetes cluster for greater peace of mind and reliability.
Observability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdfPaige Cruz
Monitoring and observability aren’t traditionally found in software curriculums and many of us cobble this knowledge together from whatever vendor or ecosystem we were first introduced to and whatever is a part of your current company’s observability stack.
While the dev and ops silo continues to crumble….many organizations still relegate monitoring & observability as the purview of ops, infra and SRE teams. This is a mistake - achieving a highly observable system requires collaboration up and down the stack.
I, a former op, would like to extend an invitation to all application developers to join the observability party will share these foundational concepts to build on:
Epistemic Interaction - tuning interfaces to provide information for AI supportAlan Dix
Paper presented at SYNERGY workshop at AVI 2024, Genoa, Italy. 3rd June 2024
https://alandix.com/academic/papers/synergy2024-epistemic/
As machine learning integrates deeper into human-computer interactions, the concept of epistemic interaction emerges, aiming to refine these interactions to enhance system adaptability. This approach encourages minor, intentional adjustments in user behaviour to enrich the data available for system learning. This paper introduces epistemic interaction within the context of human-system communication, illustrating how deliberate interaction design can improve system understanding and adaptation. Through concrete examples, we demonstrate the potential of epistemic interaction to significantly advance human-computer interaction by leveraging intuitive human communication strategies to inform system design and functionality, offering a novel pathway for enriching user-system engagements.
Encryption in Microsoft 365 - ExpertsLive Netherlands 2024Albert Hoitingh
In this session I delve into the encryption technology used in Microsoft 365 and Microsoft Purview. Including the concepts of Customer Key and Double Key Encryption.
DevOps and Testing slides at DASA ConnectKari Kakkonen
My and Rik Marselis slides at 30.5.2024 DASA Connect conference. We discuss about what is testing, then what is agile testing and finally what is Testing in DevOps. Finally we had lovely workshop with the participants trying to find out different ways to think about quality and testing in different parts of the DevOps infinity loop.
A tale of scale & speed: How the US Navy is enabling software delivery from l...sonjaschweigert1
Rapid and secure feature delivery is a goal across every application team and every branch of the DoD. The Navy’s DevSecOps platform, Party Barge, has achieved:
- Reduction in onboarding time from 5 weeks to 1 day
- Improved developer experience and productivity through actionable findings and reduction of false positives
- Maintenance of superior security standards and inherent policy enforcement with Authorization to Operate (ATO)
Development teams can ship efficiently and ensure applications are cyber ready for Navy Authorizing Officials (AOs). In this webinar, Sigma Defense and Anchore will give attendees a look behind the scenes and demo secure pipeline automation and security artifacts that speed up application ATO and time to production.
We will cover:
- How to remove silos in DevSecOps
- How to build efficient development pipeline roles and component templates
- How to deliver security artifacts that matter for ATO’s (SBOMs, vulnerability reports, and policy evidence)
- How to streamline operations with automated policy checks on container images
UiPath Test Automation using UiPath Test Suite series, part 4DianaGray10
Welcome to UiPath Test Automation using UiPath Test Suite series part 4. In this session, we will cover Test Manager overview along with SAP heatmap.
The UiPath Test Manager overview with SAP heatmap webinar offers a concise yet comprehensive exploration of the role of a Test Manager within SAP environments, coupled with the utilization of heatmaps for effective testing strategies.
Participants will gain insights into the responsibilities, challenges, and best practices associated with test management in SAP projects. Additionally, the webinar delves into the significance of heatmaps as a visual aid for identifying testing priorities, areas of risk, and resource allocation within SAP landscapes. Through this session, attendees can expect to enhance their understanding of test management principles while learning practical approaches to optimize testing processes in SAP environments using heatmap visualization techniques
What will you get from this session?
1. Insights into SAP testing best practices
2. Heatmap utilization for testing
3. Optimization of testing processes
4. Demo
Topics covered:
Execution from the test manager
Orchestrator execution result
Defect reporting
SAP heatmap example with demo
Speaker:
Deepak Rai, Automation Practice Lead, Boundaryless Group and UiPath MVP
2. 2
About Perficient
Perficient is the leading digital transformation
consulting firm serving Global 2000 and enterprise
customers throughout North America.
With unparalleled information technology, management consulting,
and creative capabilities, Perficient and its Perficient Digital agency
deliver vision, execution, and value with outstanding digital
experience, business optimization, and industry solutions.
3. 3
Perficient Profile
Founded in 1997
Public, NASDAQ: PRFT
2015 revenue $473.6 million
Major market locations:
Allentown, Atlanta, Ann Arbor, Boston, Charlotte,
Chattanooga, Chicago, Cincinnati, Columbus, Dallas,
Denver, Detroit, Fairfax, Houston, Indianapolis, Lafayette,
Milwaukee, Minneapolis, New York City, Northern California,
Oxford (UK), Southern California, St. Louis, Toronto
Global delivery centers in China and India
3,000+ colleagues
Dedicated solution practices
~95% repeat business rate
Alliance partnerships with major technology vendors
Multiple vendor/industry technology and growth awards
4. Rodney Lemery
Director, Safety and Pharmacovigilance
Perficient
• 20+ Years in Life Sciences
• BS in Biotechnology
• MPH in International Epidemiology
• PhD in Epidemiology
5. 5
• Overview of adverse drug reactions and signal
detection
• Regulatory climate surrounding social media usage
in pharmacovigilance
• Summary of literature on digital frameworks for
using social media data in pharmacovigilance
• Limitations and challenges in using these digital
frameworks for using social media data in
pharmacovigilance
• Next steps
Agenda
6. 6
• “Unintended, harmful response suspected to be
caused by the drug taken under normal
circumstances” (Lee, 2006)
• In the U.S. alone, ADRs are estimated to
account for ~100,000 deaths annually (Lazarou,
Pomeranz & Corey, 1998)
Overview of Adverse
Drug Reactions and
Signal Detection
7. 7
Signals are considered to be both previously unknown
associations and new aspects about an already known
association (Harmark, et. Al., 2016)
Overview of Adverse
Drug Reactions and
Signal Detection
8. 8
Overview of Adverse
Drug Reactions and Signal Detection
One qualitative way to evaluate the signals we receive, is using the
SNIP methodology:
• Strength
• Newness
• Importance
• Prevention
9. 9
According to a WHO publication (2002), the changing
face of pharmacovigilance includes the following:
• Improve patient care
• Improve public health and safety
• Contribute to the risk/benefit
• Promote understanding of pharmacovigilance to
the public
WHO. (2002). The Importance of Pharmacovigilance. Safety Monitoring of
Medicinal Products. Geneva: World Health Organization.
Overview of Adverse
Drug Reactions and
Signal Detection
10. 10
Overview of Adverse
Drug Reactions and Signal Detection
Signals originate from clinical and post marketed data with limitations specific to
each of these areas:
• Clinical Trials
– Tend to be small
– Not diverse
• Demographics (race, gender etc.)
• Comorbidities
• Concomitant products
• Post Marketing
– Spontaneous reporting systems
• Under-reporting *
– Electronic Health/Medical Records
– Social Media**
11. 11
Current Regulatory Climates for
Use of Social Media in Pharmacovigilance
FDA
• No regulatory requirements specific to mining social media
• Guidance on analyzing patient reported outcomes
• FDASIA (2012) and the release of a strategic plan that emphasizes innovative collection and analysis of
post-market data
EMA
• GVP guideline (2012)
– In 2014 Module VI updated and mandates regularly screening of websites under its control
– The same GVP stipulates that it is considered good practice for the MAH to monitor external sites such
as patient support or special diseases group sites
– When made aware, the GVP suggests ADRs be handled in the same manner as a spontaneous report
– In 2016 Module VI has been issued in DRAFT and changes the definition of a identifiable reporter
• Requires qualification (ie. physician, nurse, patient etc.) and only one of the following:
• Name, address, phone
12. 12
NON-REGULATORY Supporting Initiatives
• Strengthening Collaboration for Operating
Pharmacovigilance in Europe (SCOPE)
• Raise awareness of national reporting
systems for AE reporting by consumers in
Europe
• http://www.scopejointaction.eu/
• Innovative Medicines Initiative (IMI) funded the WEB-
RADR project
• Conduct scientific research into the use of
social media networks and to develop
dedicated applications (Apps) for reporting
ADRs to the National Competent Authorities
in Europe
• http://web-radr.eu/
Current Regulatory
Climate for Use
of Social Media in
Pharmacovigilance
13. 13
Summary of Literature on Digital Frameworks for
Using Social Media Data in Pharmacovigilance
A recent meta-analysis of 22 studies published in the literature summarized the
efforts and characteristics of social media pharmacovigilance activities and provided
a comprehensive framework for conducting this type of research in the future
(Sarkera, Ginn, Nikfarjama, et.al., 2015)
Sarkera, A., Ginn, R., Nikfarjama, A., O’Connora, K., Smithc, K., Jayaramanb, S., Upadhayab, T., Gonzaleza, G.. (2015). Utilizing
social media data for pharmacovigilance: A review. Journal of Biomedical Informatics, 54; pp. 202–212
17. 17
Summary of Literature on Digital Frameworks for
Using Social Media Data in Pharmacovigilance
Table 3 – Coding of Event Terms to Various Lexicons
Some studies used phonetic spelling dictionaries to try and ensure proper identification of medicinal products.
19. 19
• “….wide awake…”
• “….it feels like the Sahara desert in my mouth.”
• “I take it for diarrhea.” While another may say,
“Had to stop treatment, it was causing diarrhea.”
• “Well played tysabri...kicking butt #nosleep”
• This cipro is totally "killing" my tummy .. hiks..
• “Over-eaten again just before bed. Stuffed. Good
chance I will choke on my own vomit during sleep.
I blame #Olanzapine #timetochange #bipolar”
Summary of Literature on
Digital Frameworks for
Using Social Media Data
in Pharmacovigilance
20. 20
Summary of Literature on Digital Frameworks for
Using Social Media Data in Pharmacovigilance
Even this rather robust model doesn’t incorporate the act of evaluating and
potentially reporting on the identified ADR through regulatory channels.
21. 21
Summary of Literature on Digital Frameworks for
Using Social Media Data in Pharmacovigilance
• We are proposing an augmentation to this framework that would allow an
organization to evaluate the quality of the identified ADR and assess its
reportability to a regulatory authority or partner.
• Freifeld, Brownstein, Menone, et. Al. (2014) coined the phrase “Proto-AE” to
explain identifiable event terms in social media that had not been confirmed as
actual adverse drug reactions.
Freifeld, C.C., Brownstein, J.S., Menone, C.M., Bao, W., Filice, R., Kass-Hout, T., and Dasgupta, N.. (2014). Digital Drug Safety
Surveillance: Monitoring Pharmaceutical Products in Twitter. Drug Safety 37:343–350
22. 22
Summary of Literature on Digital Frameworks for
Using Social Media Data in Pharmacovigilance
We suggest the term proto-AE could be a useful identifier to relate the pre-reporting terms
selected through the ADR identification process.
24. 24
Summary of Literature on Digital Frameworks for
Using Social Media Data in Pharmacovigilance
Carbonell, P., Mayer, M.A., Bravo, A.. (2015). Exploring brand-name drug
mentions on Twitter for pharmacovigilance. Studies in Health Technology and
Informatics. 210:55-9.
Freifeld, C.C., Brownstein, J.S., Menone, C.M., Bao, W., Filice,
R., Kass-Hout, T., and Dasgupta, N.. (2014). Digital Drug
Safety Surveillance: Monitoring Pharmaceutical Products in
Twitter. Drug Safety 37:343–350
25. 25
Summary of Literature on Digital Frameworks for
Using Social Media Data in Pharmacovigilance
Sarkera, A., Ginn, R., Nikfarjama, A., O’Connora, K., Smithc, K., Jayaramanb, S., Upadhayab, T., Gonzaleza, G.. (2015).
Utilizing social media data for pharmacovigilance: A review. Journal of Biomedical Informatics, 54; pp. 202–212
26. 26
Limitations and Challenges in Using These Digital Frameworks
for Social Media Data in Pharmacovigilance
ETHICAL CONCERNS
• Use of identifiable data like geocode location on posting, username and other potentially personally
identifiable information
• Neglect of under-represented members of the online community; less computer literate, lack access
to the internet, or have their social media usage censored
CHALLENGES
• ADRs may be referred to using creative idiomatic expressions or terms not found within existing
medical lexicons (“….it feels like the Sahara desert in my mouth.”)
• The informal nature of social media results in a prevalence of poor grammar, spelling mistakes,
abbreviations and slang
• Differentiate between indication and adverse event
• Drugs may be described by their brand names, active ingredients, colloquialisms or generic drug
terms (e.g. ‘antibiotic’)
27. 27
Next Steps – General Support
• Perficient can assist with general strategy in implementing a methodology for social media
monitoring and reporting
• Support the design and conduct analysis of a social media targeted project (by active
substance or event of interest)
• Use of innovative technology to augment the social media framework your company
currently uses
29. 29
• How to Review, Cleanse, and Transform Clinical
Data in Oracle InForm | register
December 8, 2016
• Leveraging Oracle IDMP Enterprise Foundation
Suite for Regulatory Compliance | register
January 12, 2017
Follow Us Online
• Perficient.com/SocialMedia
• Facebook.com/Perficient
• Twitter.com/Perficient_LS
• Blogs.perficient.com/LifeSciences
31. 31
References
• Carbonell, P., Mayer, M.A., Bravo, A.. (2015). Exploring brand-name drug mentions on Twitter for pharmacovigilance. Studies in Health
Technology and Informatics. 210:55-9.
• Chokor, A., Sarker, A., Gonzalez, G. (2016). Mining the Web for Pharmacovigilance: the Case Study of Duloxetine and Venlafaxine. Masters
project report retrieved on November 2, 2016 from https://arxiv.org/abs/1610.02567
• Duh, M.S., Cremieux, P., Van Audenrode, M., Vekeman, F., Karner, P., Zhang, H., and Greenberg, P. (2016). Can social media data lead to
earlier detection of drug-related adverse events? Pharmacoepidemiology and Drug Safety, ePub
• Forrow, S., Campion, D. M., Herrinton, L. J., Nair, V. P., Robb, M. A., Wilson, M., & Platt, R. (2012). The organizational structure and governing
principles of the Food and Drug Administration's Mini‐Sentinel pilot program. Pharmacoepidemiology and drug safety, 21(S1), 12-17.
• Freifeld, C.C., Brownstein, J.S., Menone, C.M., Bao, W., Filice, R., Kass-Hout, T., and Dasgupta, N.. (2014). Digital Drug Safety Surveillance:
Monitoring Pharmaceutical Products in Twitter. Drug Safety 37:343–350
• Härmark, L., Raine, J., Leufkens, H., Edwards, I. R., Moretti, U., Sarinic, V. M., & Kant, A. (2016). Patient-Reported Safety Information: A
Renaissance of Pharmacovigilance?. Drug safety, 39(10), 883-890.
• Hazell, L., Shakir, S.A.. (2006). Under-reporting of adverse drug reactions : a systematic review. Drug Safety. 29(5):pp. 385-96.
• Lazarou, J, Pomeranz, B.H., Corey, P.N.. (1998). Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective
studies. JAMA. 279(15):pp. 1200-5.
• Lengsavath, M., Dal Pra, A., de Ferran, A. M., Brosch, S., Härmark, L., Newbould, V., & Goncalves, S. (2016). Social Media Monitoring and
Adverse Drug Reaction Reporting in Pharmacovigilance An Overview of the Regulatory Landscape. Therapeutic Innovation & Regulatory
Science, 2168479016663264.
• O’Connor, K., Pimpalkhute, P., Nikfarjam, A., Ginn, R., Smith, K. L., & Gonzalez, G. (2014). Pharmacovigilance on Twitter? Mining Tweets for
Adverse Drug Reactions. AMIA Annual Symposium Proceedings, 924–933.
• Topaz, M., Lai, K., Dhopeshwarkar, N., Seger, D.L., R., Sa’adon, Goss, F., Rozenblum, R., Zhou, L.. (2015). Clinicians’ Reports in Electronic
Health Records Versus Patients’ Concerns in Social Media: A Pilot Study of Adverse Drug Reactions of Aspirin and Atorvastatin Drug Safety